نتایج جستجو برای: relapsed hodgkin lymphoma
تعداد نتایج: 117560 فیلتر نتایج به سال:
Up to 50% of patients with Hodgkin lymphoma and diffuse large B-cell lymphoma will relapse, requiring additional therapy. Although surveillance imaging is commonly performed in clinical practice, its ability to identify asymptomatic relapses and improve survival for patients is not well defined. We evaluated the surveillance imaging role in relapse detection and reviewed its impact on survival ...
Despite great strides in the management of B-cell non-Hodgkin and Hodgkin lymphoma, peripheral T-cell lymphoma (PTCL) remains a therapeutic challenge. As Petrich and Rosen thoroughly describe in this issue of ONCOLOGY,[1] there are several new agents available for the management of PTCL. Unfortunately, however, outcomes remain poor, especially when compared with those seen in B-cell non-Hodgkin...
Background : Hodgkin lymphoma is a type of immune system malignancies, constituting about 30% of all cases of lymphomas. It is divided into four subgroups based on histopathologic findings. Recent reports indicate that SDF1 chemokine plays a major role in the development, survival and metastasis of many cancers, including breast, prostate and pancreas. So far, its expression and especially re...
Primary mediastinal choriocarcinoma is a rare extragonadal germ cell malignancy. We describe the first case of a patient who developed mediastinal choriocarcinoma after treatment for Hodgkin lymphoma (HL). A 25-year-old man with classic HL, nodular sclerosis subtype, underwent treatment with splenectomy followed by radiation therapy. Unfortunately, his disease relapsed with a paraspinal mass, a...
OBJECTIVE To evaluate the use of high-dose sequential chemotherapy in a Brazilian population. METHODS High-dose cyclophosphamide followed by autologous hematopoietic stem cell transplantation is an effective and feasible therapy for refractory/relapsed lymphomas; this regimen has never before been evaluated in a Brazilian population. All patients (106 with high-grade non-Hodgkin lymphoma and ...
Although frontline treatment of advanced Hodgkin lymphoma (HL) produces high cure rates, disease either will not respond to or will relapse after initial therapy in approximately a quarter of patients. Many patients with disease relapse can be successfully salvaged with second-line chemotherapy followed by autologous stem cell transplantation (ASCT). Patients whose disease relapses after ASCT a...
Background: Burkitt lymphoma is a common subtype of non-Hodgkin lymphoma in children. It has a rapid and aggressive clinical course with frequent involvement of bone marrow and central nervous system. Systemic chemotherapy is the mainstay of the treatment for this malignancy in children. In this systematic review, we discuss autologous and allogeneic hematopoietic stem cell transplantation (HSC...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید